HCV entry
HCV entry and neutralizing antibodies: lessons from viral variants.
6
Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E
9
Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
10
Cholesterol uptake and hepatitis C virus entry.
9
SCARB1 variants and HCV infection: Host susceptibility is lost in translation
11
Hepatitis C virus entry.
42
Etude biochimique et fonctionnelle de la glycoprotéine E1 du virus de l'Hépatite C (HCV)
249
Claudins in viral infection: from entry to spread
31
Enabling rapid development of multimodal data entry applications
12
Live or let die : intra-sectoral lobbying on entry
36
Multimodal Field Data Entry: Performance and Usability Issues
12
Impact of HCV treatment and depressive symptoms on adherence to HAART among coinfected HIV-HCV patients: results from the ANRS-CO13-HEPAVIH cohort.
24
Access Pricing and Entry in the Postal Sector
24
Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort
12
Host genetics predict clinical deterioration in HCV-related cirrhosis
14
Coordination of origin licensing and cell cycle entry
170
Étude de l'acylation de la protéine Core du virus de l'hépatite C (HCV) et son impact sur la maturation de la nucléocapside
127
Role of community-based research in advocating HCV prevention and care
3
New insights into HCV replication in original cells from Aedes mosquitoes
12
Antiviral therapy in hemodialyzed HCV patients: efficacy, tolerance and treatment strategy
27